Expres2ion Biotech Holding Stock Beneish M Score
| EXPRS2 Stock | SEK 18.74 0.38 1.99% |
ExpreS2ion |
At this time, ExpreS2ion Biotech's M Score is inapplicable. The earnings manipulation may begin if ExpreS2ion Biotech's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by ExpreS2ion Biotech executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of ExpreS2ion Biotech's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-4.84
Beneish M Score - Inapplicable
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
About ExpreS2ion Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ExpreS2ion Biotech Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ExpreS2ion Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ExpreS2ion Biotech Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in ExpreS2ion Stock
ExpreS2ion Biotech financial ratios help investors to determine whether ExpreS2ion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ExpreS2ion with respect to the benefits of owning ExpreS2ion Biotech security.